Chromatography
Expansion of European Customer Services
Jun 20 2007
"The opening of this new service centre represents an expansion of ESA's authorised, trained service and support network to better serve our rapidly growing user base," said Eddie Goodall (General Manager, ESA Biosciences in Europe). Mr. Goodall continued, "The Corona CAD has been widely adopted by many leading pharmaceutical companies because it solves analytical challenges that no other technology can address. The ideal complement to UV detection, Corona delivers orders-of-magnitude advantages in sensitivity, dynamic range, consistency, reproducibility, and ease of use, providing universal high-performance liquid chromatography (HPLC) detection of virtually any non-volatile or semi-volatile compound, including proteins, lipids, carbohydrates, and small molecules. Since its introduction in late 2004, the Corona has proven essential for anyone who is focused on accelerating product development or ensuring the timely roll-out of products that meet quality specifications."
ESA Biosciences, Inc. enables answers to pressing applications challenges by applying its expertise in specialty HPLC detection and electrochemistry, combined with components, kits, and reagents, for analytical laboratories, commercial diagnostics laboratories, and the clinical point-of-care setting.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan